A Phase 2 Trial of 61Cu-NU101 PET/CT Compared Against Current Standard-of-care 18F-piflufolastat (Pylarify®) PET/CT.
NCT07635524
·
clinicaltrials.gov ↗
PHASE2
Phase
NOT_YET_RECRUITING
Status
34
Enrollment
OTHER
Sponsor class
Conditions
Prostate Cancer
Interventions
DRUG:
Cu-NU101
Sponsor
Hoag Memorial Hospital Presbyterian
Collaborators
[object Object]
[object Object]